Pre- and intratherapeutic predictors of overall survival in patients with advanced metastasized castration-resistant prostate cancer receiving Lu-177-PSMA-617 radioligand therapy.

BMC Urol · 2022 · PMC9254582 · PMID 35788220

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

failed to reach significanceno p-value reported

A drop of any height in PSA levels after the first treatment cycle is accompanied by an increased survival time span, however, this finding failed to reach significance after adjusting for multiple testing.

also in 4,113 other papers

did not reach statistical significanceno p-value reported

Likewise, elevated ALP and GGT levels were associated with a decrease of median survival time, although these results were less distinct and did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.